genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2021
Allergan
News
Allergies? Blame the Ripoptosome, an Allergen-Sensing “Platform”
Bioprocessing
Pharmaron Acquires Bioprocessing Site from AbbVie
Drug Discovery
Allergan Sells Zenpep, Brazikumab as Regulators Review AbbVie $63B Deal
A-Lists
Top 10 M&A Deals of January–June 2019
Industry News
AbbVie Prepares for Life after Humira with Planned $63B Allergan Acquisition
A-Lists
What the Top 10 Biopharma CEOs Are Making
Genome Editing
Allergan to Develop Editas CRISPR Therapy EDIT-101 for LCA10
News
Mosquito Spit Disturbs Human Immune Cells for Days
Industry News
Allergan Eliminating 1400 Jobs as Dry-Eye Drug Faces Generic Competition
Industry News
Treasury Department Holds Off Repealing Anti-Inversion Rule
1
2
3
...
8
Page 1 of 8
Scroll Up
Scroll Up
